Back
Supernus Pharmaceuticals 10K Form
Sell
41
SUPN
Supernus Pharmaceuticals
Last Price:
$31.26
Seasonality Move:
11.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | SUPN/Supernus Pharmaceuticals Quarterly |
| 2023-11-08 | 10Q | SUPN/Supernus Pharmaceuticals Quarterly |
| 2023-08-08 | 10Q | SUPN/Supernus Pharmaceuticals Quarterly |
| 2023-05-09 | 10Q | SUPN/Supernus Pharmaceuticals Quarterly |
| 2022-11-09 | 10Q | SUPN/Supernus Pharmaceuticals Quarterly |
| 2022-08-08 | 10Q | SUPN/Supernus Pharmaceuticals Quarterly |
Receive SUPN News And Ratings
See the #1 stock for the next 7 days that we like better than SUPN
SUPN Financial Statistics
Sales & Book Value
| Annual Sales: | $661.8M |
|---|---|
| Cash Flow: | $44.2M |
| Price / Cash Flow: | 10.22 |
| Annual Sales: | $18.58 |
| Price / Book: | 1.68 |
Profitability
| EPS (TTM): | 1.32220 |
|---|---|
| Net Income (TTM): | $73.9M |
| Gross Margin: | $583.9M |
| Return on Equity: | 7.61% |
| Return on Assets: | 5.59% |
Supernus Pharmaceuticals Earnings Forecast
Key Supernus Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 16 years for SUPN is 88.23%.
-
The Selling, General & Administrative Expenses for SUPN have been equal to 48.59% of Gross Profit Margin.
-
The Research & Development expenses have been 16.44% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of SUPN is 11.16% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 10 years.
Supernus Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SUPN |
| CUSIP: | 868459 |
| Website: | supernus.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.35 |
| Quick Ratio: | 2.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.68 |
|---|---|
| Forward P/E Ratio: | 12.31 |
SUPN Technical Analysis vs Fundamental Analysis
Sell
41
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a SellThe current Supernus Pharmaceuticals [SUPN] share price is $31.26. The Score for SUPN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.